Atlas Trials

Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia

Clinical trial NCT03229746 · COMPLETED

Trial details

NCT number
NCT03229746
Sponsor
Assiut University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2017-08-01
Primary completion
2018-06-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.